Möchten Sie über diese Zeitschrift informiert bleiben? Klicken Sie bitte auf die Buttons, um unsere Alerts zu abonnieren.
Möchten Sie über diese Zeitschrift informiert bleiben? Klicken Sie bitte auf die Buttons, um unsere Alerts zu abonnieren.
Saccharomyces cerevisiae-based probiotic as novel anti-fungal and anti-inflammatory agent for therapy of vaginal candidiasis
in Beneficial MicrobesSearch for other papers by E. Gabrielli in
Current site
Google Scholar
Department of Diagnostic, Clinic and Public Health Medicine, University of Modena and Reggio Emilia, 41125 Modena, Italy.
Search for other papers by E. Pericolini in
Current site
Google Scholar
Search for other papers by N. Ballet in
Current site
Google Scholar
Search for other papers by E. Roselletti in
Current site
Google Scholar
Search for other papers by S. Sabbatini in
Current site
Google Scholar
Search for other papers by P. Mosci in
Current site
Google Scholar
Search for other papers by A. Cayzeele Decherf in
Current site
Google Scholar
Search for other papers by F. Pélerin in
Current site
Google Scholar
Search for other papers by S. Perito in
Current site
Google Scholar
Search for other papers by P. Jüsten in
Current site
Google Scholar
Search for other papers by A. Vecchiarelli in
Current site
Google Scholar
Previously we demonstrated that the treatment with live Saccharomyces cerevisiae exerts beneficial therapeutic effects against vaginal candidiasis. Here, we address potential mechanisms particularly examining the probiotic capacity to modulate both fungus and host-related factors. We show that the S. cerevisiae-based probiotic markedly affects the expression of virulence traits of Candida albicans such as aspartyl proteinases (SAPs) as well as hyphae-associated proteins Hwp1 and Ece1 in the vaginal cavity. On the host side, the probiotic suppression of the influx of neutrophils caused by the fungus into the vaginas of the mice is likely related to: (1) lower production of interleukin-8; and (2) inhibition of SAPs expression. However, these neutrophils displayed reactive oxygen species hyperproduction and increased killing activity as compared to the neutrophils of placebo-treated mice. There was no evidence of any cytotoxic effect by the probiotic, either when used in vivo on vaginal epithelial cell and organ architecture, or in in vitro in human vaginal epithelium. Inactivated yeast cells did not affect any of the factors above. In summary, the data suggest that the beneficial effect exerted by this S. cerevisiae-based probiotic is the result of its interference with the expression of fungus virulence factors coupled with the modulation of the inflammatory response of the host.
-
Badia, R., Brufau, M.T., Guerrero-Zamora, A.M., Lizardo, R., Dobrescu, I., Martin-Venegas, R., Ferrer, R., Salmon, H., Martinez, P. and Brufau, J., 2012. Beta-galactomannan and Saccharomyces cerevisiae var. boulardii modulate the immune response against Salmonella enterica serovar Typhimurium in porcine intestinal epithelial and dendritic cells. Clinical and Vaccine Immunology 19: 368-376.
'Beta-galactomannan and Saccharomyces cerevisiae var ' () 19 Clinical and Vaccine Immunology : 368 -376.
-
Bistoni, F., Vecchiarelli, A., Cenci, E., Puccetti, P., Marconi, P. and Cassone, A., 1986. Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infection and Immunity 51: 668-674.
'Evidence for macrophage-mediated protection against lethal Candida albicans infection ' () 51 Infection and Immunity : 668 -674.
-
Cascio, V., Gittings, D., Merloni, K., Hurton, M., Laprade, D. and Austriaco, N., 2013. S-Adenosyl-L-methionine protects the probiotic yeast, Saccharomyces boulardii, from acid-induced cell death. BMC Microbiology 13: 35.
'S-Adenosyl-L-methionine protects the probiotic yeast, Saccharomyces boulardii, from acid-induced cell death ' () 13 BMC Microbiology : 35.
-
Cassone, A., Vecchiarelli, A. and Hube, B., 2016. Aspartyl proteinases of eukaryotic microbial pathogens: from eating to heating. PLoS Pathogens 12: e1005992.
'Aspartyl proteinases of eukaryotic microbial pathogens: from eating to heating ' () 12 PLoS Pathogens : e1005992.
-
Cavaglieri, C.R., Nishiyama, A., Fernandes, L.C., Curi, R., Miles, E.A. and Calder, P.C., 2003. Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Science 73: 1683-1690.
'Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes ' () 73 Life Science : 1683 -1690.
-
Cayzeele-Decherf, A., Pelerin, F., Leuillet, S., Douillard, B., Housez, B., Cazaubiel, M., Jacobson, G.K., Justen, P. and Desreumaux, P., 2017. Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: an individual subject meta-analysis. World Journal of Gastroenterology 23: 336-344.
'Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: an individual subject meta-analysis ' () 23 World Journal of Gastroenterology : 336 -344.
-
Cheung, Q.C., Yuan, Z., Dyce, P.W., Wu, D., DeLange, K. and Li, J., 2009. Generation of epidermal growth factor-expressing Lactococcus lactis and its enhancement on intestinal development and growth of early-weaned mice. American Journal of Clinical Nutrition 89: 871-879.
'Generation of epidermal growth factor-expressing Lactococcus lactis and its enhancement on intestinal development and growth of early-weaned mice ' () 89 American Journal of Clinical Nutrition : 871 -879.
-
Dalmasso, G., Loubat, A., Dahan, S., Calle, G., Rampal, P. and Czerucka, D., 2006. Saccharomyces boulardii prevents TNF-alpha-induced apoptosis in EHEC-infected T84 cells. Research in Microbiology 157: 456-465.
'Saccharomyces boulardii prevents TNF-alpha-induced apoptosis in EHEC-infected T84 cells ' () 157 Research in Microbiology : 456 -465.
-
Edwards-Ingram, L., Gitsham, P., Burton, N., Warhurst, G., Clarke, I., Hoyle, D., Oliver, S.G. and Stateva, L., 2007. Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae. Applied and Environmental Microbiology 73: 2458-2467.
'Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae ' () 73 Applied and Environmental Microbiology : 2458 -2467.
-
Finkel, J.S. and Mitchell, A.P., 2011. Genetic control of Candida albicans biofilm development. Nature Reviews Microbiology 9: 109-118.
'Genetic control of Candida albicans biofilm development ' () 9 Nature Reviews Microbiology : 109 -118.
-
Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2002. Guidelines for the evaluation of probiotics in food. Report of a Joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. Available at: http://tinyurl.com/zdbrkeg.
-
Gabrielli, E., Pericolini, E., Luciano, E., Sabbatini, S., Roselletti, E., Perito, S., Kasper, L., Hube, B. and Vecchiarelli, A., 2015. Induction of caspase-11 by aspartyl proteinases of Candida albicans and implication in promoting inflammatory response. Infection and Immunity 83: 1940-1948.
'Induction of caspase-11 by aspartyl proteinases of Candida albicans and implication in promoting inflammatory response ' () 83 Infection and Immunity : 1940 -1948.
-
Gabrielli, E., Sabbatini, S., Roselletti, E., Kasper, L., Perito, S., Hube, B., Cassone, A., Vecchiarelli, A. and Pericolini, E., 2016. In vivo induction of neutrophil chemotaxis by secretory aspartyl proteinases of Candida albicans. Virulence 7: 819-825.
'In vivo induction of neutrophil chemotaxis by secretory aspartyl proteinases of Candida albicans ' () 7 Virulence : 819 -825.
-
Hofs, S., Mogavero, S. and Hube, B., 2016. Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota. Journal of Microbiology 54: 149-169.
'Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota ' () 54 Journal of Microbiology : 149 -169.
-
Jubran, A., Grant, B.J., Duffner, L.A., Collins, E.G. Lanuza, D.M., Hoffman, L.A. and Tobin, M.J., 2013. Effect of pressure support vs unassisted breathing through a tracheostomy collar on weaning duration in patients requiring prolonged mechanical ventilation: a randomized trial. JAMA 309: 671-677.
'Effect of pressure support vs unassisted breathing through a tracheostomy collar on weaning duration in patients requiring prolonged mechanical ventilation: a randomized trial ' () 309 JAMA : 671 -677.
-
Kennedy, P.J., Cryan, J.F., Dinan, T.G. and Clarke, G., 2014. Irritable bowel syndrome: a microbiome-gut-brain axis disorder? World Journal of Gastroenterology 20: 14105-14125.
'Irritable bowel syndrome: a microbiome-gut-brain axis disorder? ' () 20 World Journal of Gastroenterology : 14105 -14125.
-
Kurtzman, C.P. and Robnett, C.J., 1997. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5’ end of the large-subunit (26S) ribosomal DNA gene. Journal of Clinical Microbiology 35: 1216-1223.
'Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5’ end of the large-subunit (26S) ribosomal DNA gene ' () 35 Journal of Clinical Microbiology : 1216 -1223.
-
Kurtzman, C.P. and Robnett, C.J., 1998. Identification and phylogeny of ascomycetous yeasts from analysis of nuclear large subunit (26S) ribosomal DNA partial sequences. Antonie Van Leeuwenhoek 73: 331-371.
'Identification and phylogeny of ascomycetous yeasts from analysis of nuclear large subunit (26S) ribosomal DNA partial sequences ' () 73 Antonie Van Leeuwenhoek : 331 -371.
-
Lim, P.L., Toh, M. and Liu, S.Q., 2015. Saccharomyces cerevisiae EC-1118 enhances the survivability of probiotic Lactobacillus rhamnosus HN001 in an acidic environment. Applied Microbiology and Biotechnology 99: 6803-6811.
'Saccharomyces cerevisiae EC-1118 enhances the survivability of probiotic Lactobacillus rhamnosus HN001 in an acidic environment ' () 99 Applied Microbiology and Biotechnology : 6803 -6811.
-
Looijer-van Langen, M.A. and Dieleman, L.A., 2009. Prebiotics in chronic intestinal inflammation. Inflammatory Bowel Disease 15: 454-462.
'Prebiotics in chronic intestinal inflammation ' () 15 Inflammatory Bowel Disease : 454 -462.
-
Martins, F.S., Silva, A.A., Vieira, A.T., Barbosa, F.H., Arantes, R.M., Teixeira, M.M. and Nicoli, J.R., 2009. Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties. Archives of Microbiology 191: 623-630.
'Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties ' () 191 Archives of Microbiology : 623 -630.
-
Martins, F.S., Vieira, A.T., Elian, S.D., Arantes, R.M., Tiago, F.C., Sousa, L.P., Araujo, H.R., Pimenta, P.F., Bonjardim, C.A., Nicoli, J.R. and Teixeira, M.M., 2013. Inhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in mice. Microbes and Infection 15: 270-279.
'Inhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in mice ' () 15 Microbes and Infection : 270 -279.
-
Medzhitov, R., 2007. Recognition of microorganisms and activation of the immune response. Nature 449: 819-826.
'Recognition of microorganisms and activation of the immune response ' () 449 Nature : 819 -826.
-
Mennigen, R. and Bruewer, M., 2009. Effect of probiotics on intestinal barrier function. Annals of the New York Academy of Sciences 1165: 183-189.
'Effect of probiotics on intestinal barrier function ' () 1165 Annals of the New York Academy of Sciences : 183 -189.
-
European Office for Standardization (CEN), 2009. PCR typing of probiotic strains of Saccharomyces cerevisiae(yeast). Animal feeding stuffs, CEN/TS 15790.
'PCR typing of probiotic strains of Saccharomyces cerevisiae(yeast) ', in nimal feeding stuffs, CEN/TS 15790 , ().
-
Mosci, P., Gabrielli, E., Luciano, E., Perito, S., Cassone, A., Pericolini, E. and Vecchiarelli, A., 2014. Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection. Microbes and Infection 16: 678-689.
'Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection ' () 16 Microbes and Infection : 678 -689.
-
Moyes, D.L., Wilson, D., Richardson, J.P., Mogavero, S., Tang, S.X., Wernecke, J., Hofs, S., Gratacap, R.L., Robbins, J., Runglall, M., Murciano, C., Blagojevic, M., Thavaraj, S., Forster, T.M., Hebecker, B., Kasper, L., Vizcay, G., Iancu, S.I., Kichik, N., Hader, A., Kurzai, O., Luo, T., Kruger, T., Kniemeyer, O., Cota, E., Bader, O., Wheeler, R.T., Gutsmann, T., Hube, B. and Naglik, J.R., 2016. Candidalysin is a fungal peptide toxin critical for mucosal infection. Nature 532: 64-68.
'Candidalysin is a fungal peptide toxin critical for mucosal infection ' () 532 Nature : 64 -68.
-
Naglik, J.R., Fostira, F., Ruprai, J., Staab, J.F., Challacombe, S.J. and Sundstrom, P., 2006. Candida albicans HWP1 gene expression and host antibody responses in colonization and disease. Journal of Medical Microbiology 55: 1323-1327.
'Candida albicans HWP1 gene expression and host antibody responses in colonization and disease ' () 55 Journal of Medical Microbiology : 1323 -1327.
-
Naglik, J.R., Moyes, D., Makwana, J., Kanzaria, P., Tsichlaki, E., Weindl, G., Tappuni, A.R., Rodgers, C.A., Woodman, A.J., Challacombe, S.J., Schaller, M. and Hube, B., 2008. Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiology 154: 3266-3280.
'Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis ' () 154 Microbiology : 3266 -3280.
-
Naglik, J.R., Moyes, D.L., Wachtler, B. and Hube, B., 2011. Candida albicans interactions with epithelial cells and mucosal immunity. Microbes and Infection 13: 963-976.
'Candida albicans interactions with epithelial cells and mucosal immunity ' () 13 Microbes and Infection : 963 -976.
-
Naglik, J.R., Richardson, J.P. and Moyes, D.L., 2014. Candida albicans pathogenicity and epithelial immunity. PLoS Pathogens 10: e1004257.
'Candida albicans pathogenicity and epithelial immunity ' () 10 PLoS Pathogens : e1004257.
-
Nicholson, J.K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W. and Pettersson, S., 2012. Host-gut microbiota metabolic interactions. Science 336: 1262-1267.
'Host-gut microbiota metabolic interactions ' () 336 Science : 1262 -1267.
-
Pericolini, E., Gabrielli, E., Amacker, M., Kasper, L., Roselletti, E., Luciano, E., Sabbatini, S., Kaeser, M., Moser, C., Hube, B., Vecchiarelli, A. and Cassone, A., 2015. Secretory aspartyl proteinases cause vaginitis and can mediate vaginitis caused by Candida albicans in mice. MBio 6: e00724.
'Secretory aspartyl proteinases cause vaginitis and can mediate vaginitis caused by Candida albicans in mice ' () 6 MBio : e00724.
-
Pericolini, E., Gabrielli, E., Ballet, N., Sabbatini, S., Roselletti, E., Cayzeele Decherf, A., Pelerin, F., Luciano, E., Perito, S., Justen, P. and Vecchiarelli, A., 2017. Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis. Virulence 8(1): 1-17.
'Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis ' () 8 Virulence : 1 -17.
-
Peters, B.M., Yano, J., Noverr, M.C. and Fidel Jr., P.L., 2014. Candida vaginitis: when opportunism knocks, the host responds. PLoS Pathogens 10: e1003965.
'Candida vaginitis: when opportunism knocks, the host responds ' () 10 PLoS Pathogens : e1003965.
-
Pietrella, D., Pandey, N., Gabrielli, E., Pericolini, E., Perito, S., Kasper, L., Bistoni, F., Cassone, A., Hube, B. and Vecchiarelli, A., 2013. Secreted aspartic proteases of Candida albicans activate the NLRP3 inflammasome. European Journal of Immunology 43: 679-692.
'Secreted aspartic proteases of Candida albicans activate the NLRP3 inflammasome ' () 43 European Journal of Immunology : 679 -692.
-
Pietrella, D., Rachini, A., Pines, M., Pandey, N., Mosci, P., Bistoni, F., d’Enfert, C. and Vecchiarelli, A., 2011. Th17 cells and IL-17 in protective immunity to vaginal candidiasis. PLoS ONE 6: e22770.
'Th17 cells and IL-17 in protective immunity to vaginal candidiasis ' () 6 PLoS ONE : e22770.
-
Pineton de Chambrun, G., Neut, C., Chau, A., Cazaubiel, M., Pelerin, F., Justen, P. and Desreumaux, P., 2015. A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome. Digestive and Liver Disease 47: 119-124.
'A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome ' () 47 Digestive and Liver Disease : 119 -124.
-
Pontier-Bres, R., Munro, P., Boyer, L., Anty, R., Imbert, V., Terciolo, C., Andre, F., Rampal, P., Lemichez, E., Peyron, J.F. and Czerucka, D., 2014. Saccharomyces boulardii modifies Salmonella typhimurium traffic and host immune responses along the intestinal tract. PLoS ONE 9: e103069.
'Saccharomyces boulardii modifies Salmonella typhimurium traffic and host immune responses along the intestinal tract ' () 9 PLoS ONE : e103069.
-
Ridge, J., Muller, J., Noguchi, P. and Chang, E.H., 1991. Dynamics of differentiation in human epidermoid squamous carcinoma cells (A431) with continuous, long-term gamma-IFN treatment. In vitro Cellular and Developmental Biology 27A: 417-424.
'Dynamics of differentiation in human epidermoid squamous carcinoma cells (A431) with continuous, long-term gamma-IFN treatment ' () 27A In vitro Cellular and Developmental Biology : 417 -424.
-
Sartor, R.B., 2005. Probiotic therapy of intestinal inflammation and infections. Current Opinion in Gastroenterology 21: 44-50.
'Probiotic therapy of intestinal inflammation and infections ' () 21 Current Opinion in Gastroenterology : 44 -50.
-
Shimizu, S., 2004. Routes of administration. In: Hedrich, H.J. and Bullock, G. (eds.) The laboratory mouse. Elsevier, New York, NY, USA.
'Routes of administration ', in The laboratory mouse , ().
-
Sivignon, A., De Vallee, A., Barnich, N., Denizot, J., Darcha, C., Pignede, G., Vandekerckove, P. and Darfeuille-Michaud, A., 2015. Saccharomyces cerevisiae CNCM I-3856 prevents colitis induced by AIEC bacteria in the transgenic mouse model mimicking Crohn’s disease. Inflammatory Bowel Disease 21: 276-286.
'Saccharomyces cerevisiae CNCM I-3856 prevents colitis induced by AIEC bacteria in the transgenic mouse model mimicking Crohn’s disease ' () 21 Inflammatory Bowel Disease : 276 -286.
-
Sougioultzis, S., Simeonidis, S., Bhaskar, K.R., Chen, X., Anton, P.M., Keates, S., Pothoulakis, C. and Kelly, C.P., 2006. Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. Biochemical and Biophysical Research Communications 343: 69-76.
'Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression ' () 343 Biochemical and Biophysical Research Communications : 69 -76.
-
Spiller, R., Pelerin, F., Cayzeele Decherf, A., Maudet, C., Housez, B., Cazaubiel, M. and Justen, P., 2016. Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation. United European Gastroenterology Journal 4: 353-362.
'Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation ' () 4 United European Gastroenterology Journal : 353 -362.
-
Sudbery, P.E., 2011. Growth of Candida albicans hyphae. Nature Reviews Microbiology 9: 737-748.
'Growth of Candida albicans hyphae ' () 9 Nature Reviews Microbiology : 737 -748.
-
Tremaroli, V. and Backhed, F., 2012. Functional interactions between the gut microbiota and host metabolism. Nature 489: 242-249.
'Functional interactions between the gut microbiota and host metabolism ' () 489 Nature : 242 -249.
-
Van Niel, C.W., Feudtner, C., Garrison, M.M. and Christakis, D.A., 2002. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 109: 678-684.
'Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis ' () 109 Pediatrics : 678 -684.
-
Vance, R.E., Isberg, R.R. and Portnoy, D.A., 2009. Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe 6: 10-21.
'Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system ' () 6 Cell Host Microbe : 10 -21.
-
Vecchiarelli, A., Gabrielli, E. and Pericolini, E., 2015. Experimental models of vaginal candidiasis and inflammation. Future Microbiology 10: 1265-1268.
'Experimental models of vaginal candidiasis and inflammation ' () 10 Future Microbiology : 1265 -1268.
-
Wachtler, B., Wilson, D., Haedicke, K., Dalle, F. and Hube, B., 2011. From attachment to damage: defined genes of Candida albicans mediate adhesion, invasion and damage during interaction with oral epithelial cells. PLoS ONE 6: e17046.
'From attachment to damage: defined genes of Candida albicans mediate adhesion, invasion and damage during interaction with oral epithelial cells ' () 6 PLoS ONE : e17046.
-
Williams, N.T., 2010. Probiotics. American Journal of Health System Pharmacy 67: 449-458.
'Probiotics ' () 67 American Journal of Health System Pharmacy : 449 -458.
| Insgesamt | Letzte 365 Tage | In den letzten 30 Tagen | |
|---|---|---|---|
| Aufrufe von Kurzbeschreibungen | 0 | 0 | 0 |
| Gesamttextansichten | 830 | 354 | 21 |
| PDF-Downloads | 1022 | 441 | 9 |
Saccharomyces cerevisiae-based probiotic as novel anti-fungal and anti-inflammatory agent for therapy of vaginal candidiasis
in Beneficial MicrobesSearch for other papers by E. Gabrielli in
Current site
Google Scholar
PubMed
Department of Diagnostic, Clinic and Public Health Medicine, University of Modena and Reggio Emilia, 41125 Modena, Italy.
Search for other papers by E. Pericolini in
Current site
Google Scholar
PubMed
Search for other papers by N. Ballet in
Current site
Google Scholar
PubMed
Search for other papers by E. Roselletti in
Current site
Google Scholar
PubMed
Search for other papers by S. Sabbatini in
Current site
Google Scholar
PubMed
Search for other papers by P. Mosci in
Current site
Google Scholar
PubMed
Search for other papers by A. Cayzeele Decherf in
Current site
Google Scholar
PubMed
Search for other papers by F. Pélerin in
Current site
Google Scholar
PubMed
Search for other papers by S. Perito in
Current site
Google Scholar
PubMed
Search for other papers by P. Jüsten in
Current site
Google Scholar
PubMed
Search for other papers by A. Vecchiarelli in
Current site
Google Scholar
PubMed
Previously we demonstrated that the treatment with live Saccharomyces cerevisiae exerts beneficial therapeutic effects against vaginal candidiasis. Here, we address potential mechanisms particularly examining the probiotic capacity to modulate both fungus and host-related factors. We show that the S. cerevisiae-based probiotic markedly affects the expression of virulence traits of Candida albicans such as aspartyl proteinases (SAPs) as well as hyphae-associated proteins Hwp1 and Ece1 in the vaginal cavity. On the host side, the probiotic suppression of the influx of neutrophils caused by the fungus into the vaginas of the mice is likely related to: (1) lower production of interleukin-8; and (2) inhibition of SAPs expression. However, these neutrophils displayed reactive oxygen species hyperproduction and increased killing activity as compared to the neutrophils of placebo-treated mice. There was no evidence of any cytotoxic effect by the probiotic, either when used in vivo on vaginal epithelial cell and organ architecture, or in in vitro in human vaginal epithelium. Inactivated yeast cells did not affect any of the factors above. In summary, the data suggest that the beneficial effect exerted by this S. cerevisiae-based probiotic is the result of its interference with the expression of fungus virulence factors coupled with the modulation of the inflammatory response of the host.
| Insgesamt | Letzte 365 Tage | In den letzten 30 Tagen | |
|---|---|---|---|
| Aufrufe von Kurzbeschreibungen | 0 | 0 | 0 |
| Gesamttextansichten | 830 | 354 | 21 |
| PDF-Downloads | 1022 | 441 | 9 |
